Company Quick10K Filing
Musclepharm
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-10-04 Enter Agreement, Off-BS Arrangement, Other Events, Exhibits
8-K 2019-09-16 Other Events
8-K 2019-06-06 Accountant
8-K 2019-05-31 Accountant, Exhibits
8-K 2019-04-30 Exhibits
8-K 2019-03-08 Amendment
8-K 2018-12-07
8-K 2018-11-30
8-K 2018-11-13 Earnings, Exhibits
8-K 2018-10-01 Accountant, Exhibits
8-K 2018-09-04 Regulation FD
8-K 2018-08-14 Earnings, Exhibits
8-K 2018-05-14 Earnings, Exhibits
8-K 2018-03-28 Earnings, Exhibits
8-K 2018-02-26 Officers, Exhibits

Musclepharm Financials

-

MSLP Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Apollo Education (APOL) 1,063,295 1,955,243 886,324 2,000,328 0 -19,719 98,213 579,272
China Crawfish (CACA) 2 0 0 0 -4 -4 -3
Mirenco (MREO)
Weyland Tech (WEYL) 10,602 5,280 29,462 -958 -4,242 -4,099 -5,303
Lingo Media (LMDC) 1,302 743 0 0 0 0 -0
Granite Real Estate (GRP)
Wewin Group (WWIN) 26 114 5 20 -95 -95 -20
MWF Global (MWF) 0 0 -34 -34 -1
Frontier Digital Media Group (FDMG) 5 31 32 0 -29 -29 -3
Brighthouse Life Insurance Co of Ny (BHNY) 9,065,749 8,029,864 236,819 0 0 2,514 -190,199
G-Mes Holdings (GMES) 1,262 812 652 609 67 141 -31
Baynon (BNON) 11 145 0 0 -21 -20 99
Immune Therapeutics (IMUN) 0 24 12,553 0 34 -5,080 -5,079 -21
Green Planet Bio Engineering (GPLB) 3,001 0 272 0 0 -38 -38 3,001
Blue Sphere (BLSP) 894 43,956 86,868 7,950 2,700 -14,453 -14,295 8,802
Therapeutic Solutions (TSOI) 0 367 1,851 13 10 -1,579 -1,236 481
Stem Holdings (STEMH) 40,803 5,703 958 364 -8,070 -7,496 -5,454
SpringWorks (SWTX)
Clean Coal Technologies (CCTC) 27 16,749 0 0 -5,795 -3,052 894
Ryanair Holdings (RYAA) 13,250,700 8,035,800 0 0 0 0 -34,900

Balance Sheet ($'000)2011-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash66098,4838,6565,6845,4123,3163,7692,9501,0204,7844,1703,4577,0819,05413,0525,8944,9433,0163,5534,8786,2285,1142,4421,749
Accounts Receivable2,5693,3028,0289,23510,91113,74119,63419,19823,22016,64418,95924,60715,58622,00322,33920,21715,87213,35315,23613,40813,08716,66816,92516,27816,235
Inventory16,65419,76924,02721,06913,87214,85019,32012,5498,6136,9418,0478,5686,1146,1336,2746,4847,7387,6517,324
PP&E9082,0312,2462,3372,8553,9757,1288,2179,57010,43710,47911,09710,55110,65310,6987,9737,4937,3627,2587,1377,1466,6776,6936,7414,834
Assets5,0466,76720,53723,25141,54752,15865,61866,93379,61066,35667,90175,09162,24363,78161,23350,62738,33534,09631,10929,75430,11833,82633,89130,39728,348
Accounts Payable24,29123,90028,09727,76128,82637,83440,44239,65239,36539,09836,0939,62510,8919,1349,39711,74214,89716,56220,672
Long-Term Debt
Liabilities18,01716,52513,31010,64118,87332,42330,82028,83941,52142,97646,93256,92267,79273,84973,12165,63054,77538,97638,52539,76841,57646,36048,53246,01245,825
Stockholders' Equity-12,971-9,7587,22712,60922,67519,73534,79838,09338,08923,38020,96918,169-5,549-10,068-11,888-15,003-16,440-4,880-7,416-10,014-11,458-12,534-14,641-15,615-17,477
Income Statement ($'000)2011-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Revenue22,56125,48025,34437,49250,20971,60547,76832,67141,32250,47633,98241,07842,91232,86730,69426,02626,00926,19224,39625,55826,54727,10427,388
Cost of Revenue14,39617,56717,93827,78532,33645,49232,81225,13826,93832,97823,51226,49927,69922,18120,49717,64919,53918,57616,35917,23618,32820,92118,595
Gross Profit8,1657,9137,4069,70817,87326,11414,9577,53314,38417,49810,47014,57915,21310,68610,1978,3776,4707,6168,0378,3228,2198,3348,793
R&D1,0971,1647351,0019659211,437928863531270205137152199154212221185
SG&A1,8722,3573,6525,4734,9625,1214,6474,6424,2434,4243,9373,3372,8862,8293,4682,8882,5462,6542,975
Tax00087834595-138402171113170180287624206934104
Net Income-7,362-2,422-3,946-3,9882,7367,090603-16,236-7,479-7,025-27,648-9,706-6,605-4,196-1,4478,771-3,149-3,149-2,128-2,547-2,305-1,074-1,978
Cash Flow ($'000)2011-12-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-30
Cash Operating-3,207-1,958-2,881
Cash Investing-235-119-2,575
Cash Financing11,9232,2452,496